R.H. Bluestein & Co’s Qiagen QGEN Stock Holding History

R.H. Bluestein & Co’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-4,540	Closed	-$200K	–	340
2020 Q1	$200K	Buy	+4,540	New	+$177K	0.02%	262

Other funds holding QGEN

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

R.H. Bluestein & Co's QGEN Position: Q2 2020 in Review

R.H. Bluestein & Co sold out of Qiagen (QGEN) in Q2 2020, closing a stake of 4,540 shares — an estimated $200K sold.

R.H. Bluestein & Co first reported a position in QGEN in Q1 2020 and held it in 1 quarter. The position peaked at $200K in Q1 2020. 275 funds tracked by Wall St. Rank hold QGEN as of Q2 2020.

R.H. Bluestein & Co reported no remaining Qiagen position as of Q2 2020 after selling out during the quarter.
R.H. Bluestein & Co sold 4,540 Qiagen shares in Q2 2020, an estimated $200K.
R.H. Bluestein & Co first reported a position in Qiagen in Q1 2020 and held it in 1 quarter.
R.H. Bluestein & Co's Qiagen position peaked at $200K in Q1 2020.
275 funds tracked by Wall St. Rank held Qiagen as of Q2 2020.

Based on R.H. Bluestein & Co's 13F filing for Q2 2020, filed 12 Aug 2020.